Showing results (71-80 of 13,832) with videos related to

Sort By:
Pageof 1,384
Hepatology (Baltimore, Md.)|June 26, 2010
Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavageJiejie Xu, Xiaojing Yun, Jianhai Jiang, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cellsSteve S Choi, Rafal P Witek, Liu Yang, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcomeKui Wang, Jian Liu, Zhen-Lin Yan, et al.
Hepatology (Baltimore, Md.)|June 22, 2010
Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progressionEmmanouil Sinakos, Hanns-Ulrich Marschall, Kris V Kowdley, et al.
Hepatology (Baltimore, Md.)|July 2, 2010
Novel mechanism of antibodies to hepatitis B virus in blocking viral particle release from cellsAvidan U Neumann, Sandra Phillips, Idit Levine, et al.
Hepatology (Baltimore, Md.)|June 29, 2010
Conditional beta-catenin loss in mice promotes chemical hepatocarcinogenesis: role of oxidative stress and platelet-derived growth factor receptor alpha/phosphoinositide 3-kinase signalingXu-Feng Zhang, Xinping Tan, Gang Zeng, et al.
Hepatology (Baltimore, Md.)|June 29, 2010
HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosisKatrina J Allen, Nadine A Bertalli, Nicholas J Osborne, et al.
Hepatology (Baltimore, Md.)|June 29, 2010
Transforming growth factor-beta induces senescence in hepatocellular carcinoma cells and inhibits tumor growthSerif Senturk, Mine Mumcuoglu, Ozge Gursoy-Yuzugullu, et al.
Hepatology (Baltimore, Md.)|September 11, 2010
Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis CRobert Roomer, Bettina E Hansen, Harry L A Janssen, et al.
Hepatology (Baltimore, Md.)|September 11, 2010
Prediction of sustained response to peginterferon alfa-2b for hepatitis B e antigen-positive chronic hepatitis B using on-treatment hepatitis B surface antigen declineMilan J Sonneveld, Vincent Rijckborst, Charles A B Boucher, et al.
Pageof 1,384